$1.110
+0.042 (+3.74%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SNOA Prediction & Forecast by Similar Chart Analysis
Alphio's SNOA stock price prediction model matches the current Sonoma Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.13 (+1.40%). The 1-week path is $1.14 (+2.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Sonoma Pharmaceuticals Inc Stock?
Sonoma Pharmaceuticals Inc (SNOA) appears to be a good buy right now due to its recent FDA clearance for the Microdacyn Wound Solution, which is expected to enhance market competitiveness. The stock is currently priced at $1.11, significantly below its 52-week high of $3.95, indicating potential for upside. Additionally, the company reported a 48.3% year-over-year revenue increase in Q4 2026, reaching $5.56 million, which reflects a strong recovery trend. However, a key risk is the forward P/E ratio of 46.08, suggesting that the stock may be overvalued relative to its earnings potential.
SNOA stock price ended at $1.11 on Friday, after rising +3.74%
Sonoma Pharmaceuticals Inc (SNOA) last closed at $1.11, gaining +3.74%. These facts feed the 1-day and 1-week SNOA price prediction above.
Analyst Consensus
Sonoma Pharmaceuticals Inc (SNOA): 2 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Sonoma Pharmaceuticals Inc (SNOA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SNOA, ranked by similarity.
Seasonality analysis for SNOA
Historically the probability of a positive November return for SNOA is 43.18%. July offers the highest probability of a positive month at 66.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SNOA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $3.30 | $3.86 | $4.03 | +248.19% |
| Dec 2026 | $3.78 | $4.08 | $4.90 | +267.80% |
In 2026, Sonoma Pharmaceuticals Inc (SNOA) is projected to range from $3.30 to $4.90.
Sonoma Pharmaceuticals Inc 2026 monthly forecast
In Nov 2026, Sonoma Pharmaceuticals Inc is projected to average $3.86, with a low of $3.30 and high of $4.03.
In Dec 2026, Sonoma Pharmaceuticals Inc is projected to average $4.08, with a low of $3.78 and high of $4.90.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.